NCT00229424 - Verification Study on Lafutidine in Mild Reflux Oesophagitis - Double Blind Controlled Study With Famotidine - | Biotech Hunter

Enrollment

325

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

January 31, 2007

Conditions

Gastroesophageal Reflux

Interventions

DRUG

Lafutidine

Oral administration of lafutidine by 20mg/day along with famotidine placebo

DRUG

Famotidine

Oral administration of famotidine by 40mg/day along with lafutidine placebo

OTHER

Placebo

Oral administration of lafutidine placebo along with famotidine placebo

Trial Locations (1)

Tohoku University Hospital, 1-1, Seiryo-cho, Aoba-ku, Sendai, Miyagi